Form D · Biotechnology
Theraclone Sciences, Inc.
Seattle, WA · CIK 0001310967
Offering snapshot reported May 7, 2015 · SEC filing
- Reported sold
- $3.08M Offering amount: $4.41M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 24, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2015 | Initial | $3,080,000 | No comparison | 12 | SEC filing |
| Jul 29, 2013 | Amendment | $6,000,000 | $0vs Jul 29, 2013 | 2 | SEC filing |
| Jul 29, 2013 | Initial | $6,000,000 | No comparison | 2 | SEC filing |
| Mar 26, 2013 | Initial | $4,000,000 | No comparison | 18 | SEC filing |
| Nov 23, 2011 | Amendment | $11,584,603 | $1,000,000vs Sep 12, 2011 | 13 | SEC filing |
| Sep 12, 2011 | Initial | $10,584,603 | No comparison | 12 | SEC filing |
| Mar 17, 2010 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Mar 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-239360
The total offering amount includes the exercise price of warrants, which warrants may never be exercised.
Source: Form D, filed May 7, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Witold Cieplak | Executive |
| David Fanning | Director, Executive |
| Steven Gillis | Director, Executive |
| William Greene | Director |
| Russ Hawkinson | Executive |
| Wende Hutton | Director |
| Teri Koller | Executive |
| Christopher Mirabelli | Director |
| Eleanor Ramos | Executive |
| Wendye Robbins | Director |
| Clifford Stocks | Director, Executive |
| Kristine Swiderek | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1124 Columbia St Suite 300
Seattle, WA, 98104
Seattle, WA, 98104